CU Rx EM PGY2 (@curxpgy2em) 's Twitter Profile
CU Rx EM PGY2

@curxpgy2em

CU Emergency Medicine Pharmacy Residency program

ID: 1316179246788874241

linkhttps://pharmacy.cuanschutz.edu/academics/residencies/pgy2-emergency-medicine-residency calendar_today14-10-2020 00:49:30

56 Tweet

123 Followers

76 Following

Richard Zane MD (@richardzane) 's Twitter Profile Photo

Patients are at the center of everything we do. Thanks to all who made this drive-through clinic to vaccinate 10,000 people possible. University of Colorado Anschutz uchealth #OnwardTogether #COVID19 #CovidVaccine #ScienceMatters

CU Rx EM PGY2 (@curxpgy2em) 's Twitter Profile Photo

We are so excited Dr. Kyle Coronado is coming back to CU Department of Emergency Medicine for EM Pharmacy PGY2! Kyle joins us from University of Wisconsin Pharmacy PGY1 and completed his PharmD education at CU School of Pharmacy. DenverEM CU Pharmacy #thefutureisbright

We are so excited Dr. Kyle Coronado is coming back to <a href="/CUEmergency/">CU Department of Emergency Medicine</a> for EM Pharmacy PGY2!  Kyle joins us from University of Wisconsin Pharmacy PGY1 and completed his PharmD education at CU School of Pharmacy.  <a href="/DenverEMed/">DenverEM</a> <a href="/CUPharmacy/">CU Pharmacy</a> #thefutureisbright
DenverEM (@denveremed) 's Twitter Profile Photo

Great review of outpatient CAP treatment by our amazing ED pharmacist Gabby Jacknin. That "Z-Pak" is only good in otherwise healthy patients in areas of low macrolide resistance. #EMConf

Great review of outpatient CAP treatment by our amazing ED pharmacist Gabby Jacknin. That "Z-Pak" is only good in otherwise healthy patients in areas of low macrolide resistance.
#EMConf
CU Rx EM PGY2 (@curxpgy2em) 's Twitter Profile Photo

We are so excited to announce Jordan Jenrette, PharmD as our EM PGY2 for the 2022-2023 year! Jordan Jenrette joins us from University of Colorado PGY1 and completed her PharmD education at CU School of Pharmacy. CU Department of Emergency Medicine DenverEM CU Pharmacy #thefutureisbright

We are so excited to announce Jordan Jenrette, PharmD as our EM PGY2 for the 2022-2023 year! <a href="/JJenretteRx/">Jordan Jenrette</a> joins us from University of Colorado PGY1 and completed her PharmD education at CU School of Pharmacy.  <a href="/CUEmergency/">CU Department of Emergency Medicine</a> <a href="/DenverEMed/">DenverEM</a> <a href="/CUPharmacy/">CU Pharmacy</a> #thefutureisbright
DenverEM (@denveremed) 's Twitter Profile Photo

Beers Criteria recommends avoiding anticholinergics, antipsychotics, and benzodiazepines in the elderly. So what do we do when faced with an agitated elderly patient? #EMConf

Beers Criteria recommends avoiding anticholinergics, antipsychotics, and benzodiazepines in the elderly. So what do we do when faced with an agitated elderly patient?
#EMConf
DenverEM (@denveremed) 's Twitter Profile Photo

For BZD-refractory status epilepticus, the ESETT trial demonstrated that levetiracetam, fosphenytoin and valproate all had similar rates of efficacy and side effects. Data for 3rd-line agents is lacking. #EMConf #PharmacyPearls

For BZD-refractory status epilepticus, the ESETT trial demonstrated that levetiracetam, fosphenytoin and valproate all had similar rates of efficacy and side effects. Data for 3rd-line agents is lacking. 
#EMConf #PharmacyPearls
DenverEM (@denveremed) 's Twitter Profile Photo

Salty or sweet? Dr. Vandergriend, Pharmacy PGY-2 covered hyperosmolar therapy for increased ICP. Some poor-quality evidence supports hypertonic saline, as well as one systematic review. ncbi.nlm.nih.gov/pmc/articles/P…

Salty or sweet? 
Dr. Vandergriend, Pharmacy PGY-2 covered hyperosmolar therapy for increased ICP. 
Some poor-quality evidence supports hypertonic saline, as well as one systematic review.

ncbi.nlm.nih.gov/pmc/articles/P…